Stop TB Partnership

#htmlcaption_a #htmlcaption_b #htmlcaption_c #htmlcaption_d #htmlcaption_e

26th Coordinating Board Meeting concludes in Paris

Several critical decision points endorsed at the meeting

Stop TB Partnership Board Meeting opens in Paris

Several Ministers of Health and heads of agencies attend

Next Global Plan to Stop TB 2016-2020

First draft of the next Global Plan shared for review

Nigeria Spends Nearly US$1.5M For MDR-TB Drugs

Uses domestic resources to buy drugs

The Bedaquiline Donation Program For MDR-TB Patients

USAID-Johnson & Johnson program with GDF

GDF Information on Bedaquiline

TOP NEWS STORIES

15 April - Coordinating Board Meeting concludes with several critical decision points...Coordinating Board Meeting concludes with several critical decision points endorsed
15 April 2015 - Paris, France - The 26th Stop TB Partnership Coordinating Board has approved the first draft of the Global Plan to Stop TB 2016-2020 following a period of review by the Task Force and members of the Board. Over the next four months, online and regional consultations will seek input from anyone working with or affected by TB.

14 April - Stop TB Partnership Coordinating Board Meeting opens in ParisStop TB Partnership Coordinating Board Meeting opens in Paris
14 April 2015 - Paris, France - The 26th Stop TB Partnership Coordinating Board meeting hosted by France at the French Ministry of Health opened in Paris today. The high-level Board meeting is chaired by the Minister of Health for South Africa and Chair of the Stop TB Partnership Coordinating Board, Dr Aaron Motsoledi and the Vice Chair, Dr Joanne Carter, Executive Director of RESULTS USA.

13 April - Bending the Curve: A Global Investment Framework to Win the Fight...Bending the Curve: A Global Investment Framework to Win the Fight against TB
13 April 2015 - Paris, France - A first draft of the next Global Plan to Stop TB 2016-2020 was today shared for review on the fringes of the opening of the 26th Stop TB Partnership Coordinating Board meeting in Paris tomorrow. The Plan will call for a paradigm shift from just controlling TB to ending TB in the fight against the disease over the next five years if the world is to achieve an end to TB, as the World Health Assembly committed in 2014.

10 April - Nigeria Spends Nearly US$1.5M For Procurement Of Treatment For People...Nigeria Spends Nearly US$1.5M For Procurement Of Treatment For People With Multi-Drug Resistant TB
10, April 2015 - Geneva / Abuja - The Nigerian government sanctioned US$1.42 million to procure quality assured Second Line Drugs (SLDs) that will be used to provide treatment for 500 multi-drug resistant TB (MDR-TB) patients. The second line drugs ordered by the government will be delivered by Stop TB Partnership's Global Drug Facility starting June 2015.

10 April - Meeting: The Global Fund, GDF, representatives of Consignment Inspection...Meeting: The Global Fund, GDF, representatives of Consignment Inspection & Sampling agency, Quality Control testing laboratory
10 April 2015 - Meeting between The Global Fund, The Global Drug Facility and representatives of Consignment Inspection and Sampling agency and Quality Control testing laboratory

09 April - Not to blame the victim. Non-adherence to tuberculosis treatment...Not to blame the victim. Non-adherence to tuberculosis treatment: A multidimensional problem. What can we do?
09 April 2015 - Poor adherence, besides causing medical and psychosocial complications, undermines the quality of life of patients, impacting more strongly in families with fewer resources. The interdependent relationship between economic poverty and disease is given by the synergistic relationship between health and socioeconomic status.

01 April - The Bedaquiline Donation Program Begins TodayThe Bedaquiline Donation Program Begins Today
1, April 2015 - Geneva / Washington D.C. - Starting today countries will be able to request for bedaquiline, a new drug to treat multi-drug resistant TB, under a unique donation program following an agreement signed between The United States Agency for International Development (USAID) and the Johnson & Johnson affiliate, Janssen Therapeutics, to provide the drug free to 30,000 MDR-TB patients in over 100 low- and middle-income countries over a four year period.

TB ON THE WEB
MORE TB NEWS

ABOUT US

We set goals to fight TB globally. We grant funds to reach and treat people living with TB. We strive to raise the profile and understanding of TB. We bring the voice of TB communities to the fore. We procure drugs and diagnostics.

We work together with our partners to create a world without TB.

We are the Stop TB Partnership.

Read Our Brochure